Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.

Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered ...

Innovation must be matched with accessibility, affordability, and regulatory excellence in this digital age. At the heart of this transformation is Shaileshbhai Kaklotar, a trailblazer in ...

Google's Veo 3 image generator has taken the internet by storm, producing ultra-realistic AI videos from scratch. Here are ...

The pharmaceutical industry has long touted the promise of AI in slashing time and costs in the research and development ...

Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act. The EU Artificial Intelligence (AI ...

Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...

Not unlike Regeneron's acquisition of 23andMe, Predictive Oncology's AI-driven breakthroughs reflect a broader transformation ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will acquire 23andMe for a purchase price of $256 ...

SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...

The first drugs conceived entirely by AI will likely go on sale by the end of the decade, an pioneer in the field has said.

Europe's path to AI competitiveness lies in cutting red tape that hinders startups, not in removing AI safeguards.